Gamida Cell to Present at Upcoming Investor Conferences
March 03 2021 - 7:00AM
Business Wire
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy
company committed to cures for blood cancers and serious blood
diseases, announced today that company management will participate
in two upcoming investor conferences in March:
- H.C. Wainwright Global Life Sciences Conference, March 10,
2021. Company presentation will be available for on-demand viewing
at 7:00 a.m. ET on Tuesday, March 9, 2021.
- Oppenheimer 31st Annual Healthcare Conference, March 16-18,
2021. The company will present at 8:40 a.m. ET on Thursday, March
18, 2021.
A webcast of each presentation will be available on the
“Investors & Media” section of Gamida Cell’s website at
www.gamida-cell.com, and will be available for at least 14 days
following the event.
About Gamida Cell Gamida Cell is an advanced cell therapy
company committed to cures for patients with blood cancers and
serious blood diseases. We harness our cell expansion platform to
create therapies with the potential to redefine standards of care
in areas of serious medical need. For additional information,
please visit www.gamida-cell.com or follow Gamida Cell on LinkedIn
or Twitter at @GamidaCellTx.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210303005223/en/
For investors: Stephanie Ascher Stern Investor Relations, Inc.
stephanie.ascher@sternir.com 1-212-362-1200
For media: Rhiannon Jeselonis Ten Bridge Communications
rhiannon@tenbridgecommunications.com 1-978-417-1946
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Sep 2023 to Sep 2024